West Pharmaceutical Services Expands Capabilities in Asia

West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, today announced it has relocated to a new office facility in Seoul and expanded its warehouse capacity. This is part of West's ongoing investment in the Asia Pacific region and strategically positions West in key markets with enhanced scalability to support the future growth needs of its customers.

The newly enhanced office space is in the commercial center of Seoul and will enable West to foster deeper collaboration with existing and new customers through a dedicated training area that will host customer training, seminars, and technical exchange sessions on topics such as the evolving regulatory requirements around the world, particularly in the areas of drug safety and packaging. This expansion comes nearly one year after West announced its upgraded manufacturing facility in Jurong, Singapore, that now has capabilities to manufacture a comprehensive range of advanced containment products to meet the evolving needs of sensitive and complex molecules.

West’s new warehouse facility is strategically located in Hwaseong, close to the major local pharmaceutical companies. The warehouse space is 3,442.51m², doubling the previous storage, enhancing West's inventory management capability to meet the growing supply needs of the region in support of South Korea's ambition to become a key player in the global biologics market. This strategic move comes at a time when South Korea is emerging as a global biologic’s hub, with the government committed to quintupling the country’s biotechnology industrial output by 20351. 

Journey Hong, General Manager, West Korea, said, “Fueled by our rapid growth in South Korea, we are thrilled to be relocating to this new office facility and expanding our warehouse capability. It reflects the strength of our products, our unparalleled expertise, and our significant growth potential. The expanded space, improved location, and just-in-time supply capabilities will ensure West is best positioned to continue delivering high-quality and innovative packaging solutions for injectable drugs to support our customers’ growth and the promising biologics sector in Korea.” 

Nilesh Shah, Vice President and General Manager, Emerging Markets, West, commented, “Our vision for the APAC market is to continue to develop innovative drug delivery solutions that help make injectable medicines safe, enable greater patient adherence, and to improve the patient experience. West has played an essential role in the healthcare market for over 100 years, and by combining this recent expansion in South Korea with our high value product manufacturing capabilities in Singapore, West is well positioned to be a partner of choice in responding to the critical changes in healthcare and drug delivery in Asia.”

Source: Pressrelease